RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of GUD.TO
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Knight Therapeutics Inc. stock price up 1.05% on Monday
(Updated on Apr 29, 2024)

Buy or Hold candidate since Apr 05, 2024 Gain 6.83% PDF

The Knight Therapeutics Inc. stock price gained 1.05% on the last trading day (Monday, 29th Apr 2024), rising from $5.73 to $5.79. During the last trading day the stock fluctuated 2.65% from a day low at $5.66 to a day high of $5.81. The price has risen in 6 of the last 10 days and is up by 0.52% over the past 2 weeks. Volume fell on the last day by -16 thousand shares and in total, 25 thousand shares were bought and sold for approximately $144.30 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 4.27% during the next 3 months and, with a 90% probability hold a price between $5.56 and $6.17 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

GUD.TO Signals & Forecast

There are mixed signals in the stock today. A sell signal was issued from a pivot top point on Thursday, April 11, 2024, and so far it has fallen -1.36%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not. The Knight Therapeutics Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $5.75 and $5.52. A breakdown below any of these levels will issue sell signals. The stock had a Golden Star Signal on Thursday, June 29, 2023 in the long-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Buy
Special Signal Notification

Golden Star 12 Months

The stock had a Golden Star Signal on Thursday, June 29, 2023 in the long-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Support, Risk & Stop-loss for Knight Therapeutics Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $5.40 and $5.32. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Knight Therapeutics Inc. finds support just below today's level at $5.40. If this is broken, then the next support from accumulated volume will be at $5.32 and $5.25.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.150 between high and low, or 2.65%. For the last week the stock has had daily average volatility of 2.54%.

Our recommended stop-loss: $5.59 (-3.52%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 12 days ago.)

Trading Expectations (GUD.TO) For The Upcoming Trading Day Of Tuesday 30th

For the upcoming trading day on Tuesday, 30th we expect Knight Therapeutics Inc. to open at $5.75, and during the day (based on 14 day Average True Range), to move between $5.65 and $5.93, which gives a possible trading interval of +/-$0.144 (+/-2.48%) up or down from last closing price. If Knight Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 4.96% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $5.82 (0.52%) than the support at $5.40 (6.74%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Knight Therapeutics Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Knight Therapeutics Inc. stock to perform well in the short-term.

Current score: 2.607 Buy Candidate Unchanged

Predicted Opening Price for Knight Therapeutics Inc. of Tuesday, April 30, 2024

Fair opening price April 30, 2024 Current price
$5.75 ( 0.633%) $5.79

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for GUD.TO

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 5.90 1.96 %
R2 5.85 0.97 %
R1 5.81 0.356 %
Current price: 5.79
Support S1 5.70 -1.62 %
S2 5.66 -2.23 %
S3 5.60 -3.22 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 5.87 1.38 %
R2 5.86 1.21 %
R1 5.82 0.518 %
Current price 5.79
Support S1 5.40 -6.74%
S2 5.32 -8.12%
S3 5.25 -9.33%

FAQ

What is the symbol for Knight Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Knight Therapeutics Inc. is GUD.TO and it is traded on the TSX (Toronto Stock Exchange).

Should I buy or sell Knight Therapeutics Inc. Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Knight Therapeutics Inc. stock to perform well in the short-term.

How to buy Knight Therapeutics Inc. Stock?
Knight Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Knight Therapeutics Inc. Stock.

What's the current price of Knight Therapeutics Inc. Stock?
As of the end of day on the Apr 29, 2024, the price of an Knight Therapeutics Inc. (GUD.TO) share was $5.79.

What is the 52-week high and low for Knight Therapeutics Inc. Stock?
The 52-week high for Knight Therapeutics Inc. Stock is $5.95 and the 52-week low is $4.35.

What is the market capitalization of Knight Therapeutics Inc. Stock?
As of the Apr 29, 2024, the market capitalization of Knight Therapeutics Inc. is 585.774M.

When is the next earnings date for Knight Therapeutics Inc.?
The upcoming earnings date for Knight Therapeutics Inc. is May 09, 2024.
Click to get the best stock tips daily for free!

About Knight Therapeutics Inc.

Knight Therapeutics Inc., a specialty pharmaceutical company, develops, acquires, in-licenses, out-licenses, markets, and distributes pharmaceutical and consumer health products, and medical devices in Canada, Latin America, and internationally. It offers Nerlynx for extended adjuvant breast cancer and metastatic breast cancer; Tafasitamab for relapsed or refractory diffuse large B-cell lymphoma; Pemigatinib to treat metastatic cholangiocarcinoma... GUD.TO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT